• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Section 32 Raises $740 Million Venture Fund

    11/4/21 8:14:00 AM ET
    $COIN
    $CRWD
    $EXAS
    $RLAY
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology
    Get the next $COIN alert in real time by email

    SAN DIEGO, Nov. 4, 2021 /PRNewswire/ -- Section 32 announced today the closing of its fourth fund, raising approximately $740 million from returning and new investors. Investors in Fund 4 include leading philanthropic and non-profit organizations, educational endowments and foundations, and leaders from the technology and healthcare sectors. Section 32 Fund 4 will support companies across all stages that are pioneering innovations at the forefront of technology and healthcare. With the closing of its oversubscribed Fund 4 and to support its continued growth, Section 32 also announced the appointment of Nina Labatt to the role of Chief Operating Officer and Chief Financial Officer.

    Section 32 is a venture capital fund investing at the frontiers of technology and healthcare.

    "I'm so pleased that Nina has joined this team and I look forward to what this growing group will achieve together," commented Bill Maris, founder of Section 32. "What a privilege it is to close this fourth fund, and to thus have the continued opportunity to try to use capital as a lever to accelerate the profound positive impact technology can have on healthcare and humanity."

    The closing of Fund 4 brings assets under management for Section 32 to over $1.8B. To-date, Section 32 has made investments in more than 70 companies including Coinbase (NASDAQ:COIN), Crowdstrike (NASDAQ:CRWD), Relay Therapeutics (NASDAQ:RLAY), Thrive Earlier Detection (NASDAQ:EXAS), and Vir Biotechnology (NASDAQ:VIR). Section 32 has made eight investments from Fund 4 following an initial close of the fund in July 2021.

    Since its inception in 2017, Section 32 has grown to 16 people, including four managing partners: Bill Maris, Michael Pellini, M.D., Steve Kafka, Ph.D., and Andy Harrison, with offices in San Diego, Silicon Valley and Boston, MA. The team's cumulative career experience includes contributing to more than 130 company exits (through acquisition or public offerings) and helping to build and finance more than 50 companies with valuations in excess of $1 billion.

    With the closing of Fund 4, Section 32 added Nina Labatt to its team as its chief operating officer and chief financial officer. Nina brings more than two decades of experience to her new role and is recognized as an industry expert leading finance and operations in venture capital and private equity.

    "I'm delighted to join the team at Section 32 at this exciting time in the firm's growth," commented Nina Labatt. "I look forward to collaborating with the team to continue building world-class operations and finance functions that support our investing efforts."

    Most recently, Nina served as chief operating officer and general partner at Trinity Ventures, where she managed finance, marketing, data analytics, human resources, and legal for the firm. She also led internal strategic initiatives, structured and executed investment transactions with the investing team and participated in the firm's fundraising efforts. Previously, Ms. Labatt served as managing director, Private Equity Services for Silicon Valley Bank, as well as chief financial officer for Health Evolution Partners. Earlier in her career, Ms. Labatt was an investment banker for Goldman Sachs and Montgomery Securities. Ms. Labatt received a bachelor's degree in economics and a master's degree in international policy studies from Stanford University. She received her MBA from Harvard Business School. She was a founding member of the Northern California board of directors for the CFO Leadership Council and previously served as chairperson of the board of directors of VCBC, a non-profit association for finance professionals in venture capital.

    About Section 32

    Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies. The firm's goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life-saving medicines. Section 32 invests across the entirety of technology and life sciences. This includes software, cybersecurity, advanced communications and computation, space, climate change related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics and more. For more information, please visit Section32.com

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/section-32-raises-740-million-venture-fund-301416494.html

    SOURCE Section 32

    Get the next $COIN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $COIN
    $CRWD
    $EXAS
    $RLAY

    CompanyDatePrice TargetRatingAnalyst
    CrowdStrike Holdings Inc.
    $CRWD
    7/7/2025Overweight → Neutral
    Piper Sandler
    Coinbase Global Inc.
    $COIN
    6/25/2025$310.00 → $510.00Outperform
    Bernstein
    Coinbase Global Inc.
    $COIN
    6/17/2025$353.30Buy
    China Renaissance
    Coinbase Global Inc.
    $COIN
    6/11/2025Outperform
    William Blair
    CrowdStrike Holdings Inc.
    $CRWD
    6/6/2025$371.00Outperform → Mkt Perform
    Bernstein
    CrowdStrike Holdings Inc.
    $CRWD
    6/4/2025$405.00 → $500.00Outperform
    BMO Capital Markets
    CrowdStrike Holdings Inc.
    $CRWD
    6/4/2025$440.00Outperform → In-line
    Evercore ISI
    CrowdStrike Holdings Inc.
    $CRWD
    6/4/2025$475.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Conroy Kevin T bought $1,001,325 worth of shares (19,500 units at $51.35), increasing direct ownership by 2% to 1,074,191 units (SEC Form 4)

      4 - EXACT SCIENCES CORP (0001124140) (Issuer)

      11/13/24 12:56:28 PM ET
      $EXAS
      Medical Specialities
      Health Care

    $COIN
    $CRWD
    $EXAS
    $RLAY
    SEC Filings

    See more
    • SEC Form 144 filed by Vir Biotechnology Inc.

      144 - Vir Biotechnology, Inc. (0001706431) (Subject)

      7/1/25 4:25:23 PM ET
      $VIR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 144 filed by CrowdStrike Holdings Inc.

      144 - CrowdStrike Holdings, Inc. (0001535527) (Subject)

      7/1/25 4:10:56 PM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by CrowdStrike Holdings Inc.

      144 - CrowdStrike Holdings, Inc. (0001535527) (Subject)

      6/30/25 6:02:26 PM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CrowdStrike downgraded by Piper Sandler

      Piper Sandler downgraded CrowdStrike from Overweight to Neutral

      7/7/25 8:13:13 AM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology
    • Bernstein reiterated coverage on Coinbase Global with a new price target

      Bernstein reiterated coverage of Coinbase Global with a rating of Outperform and set a new price target of $510.00 from $310.00 previously

      6/25/25 8:34:28 AM ET
      $COIN
      Finance: Consumer Services
      Finance
    • China Renaissance initiated coverage on Coinbase Global with a new price target

      China Renaissance initiated coverage of Coinbase Global with a rating of Buy and set a new price target of $353.30

      6/17/25 7:49:17 AM ET
      $COIN
      Finance: Consumer Services
      Finance

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gandhi Sameer K sold $3,202,670 worth of shares (6,250 units at $512.43) (SEC Form 4)

      4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)

      7/8/25 8:00:06 PM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology
    • Chairman and CEO Armstrong Brian converted options into 25,000 shares and sold $8,457,278 worth of shares (25,000 units at $338.29) (SEC Form 4)

      4 - Coinbase Global, Inc. (0001679788) (Issuer)

      7/3/25 1:33:36 PM ET
      $COIN
      Finance: Consumer Services
      Finance
    • Chief Legal Officer Grewal Paul exercised 10,000 shares at a strike of $26.26 and sold $3,486,433 worth of shares (10,000 units at $348.64) (SEC Form 4)

      4 - Coinbase Global, Inc. (0001679788) (Issuer)

      7/3/25 1:32:58 PM ET
      $COIN
      Finance: Consumer Services
      Finance

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Coinbase Announces Date of Second Quarter 2025 Financial Results

      Coinbase Global, Inc. (the "Company" or "Coinbase") announced today that it will publish its second quarter 2025 shareholder letter, including financial results, on its Investor Relations website at investor.coinbase.com on Thursday, July 31, 2025, after market close. The Company will hold a question and answer session to discuss its financial results at 2:30 p.m. PT that same day. Starting on July 24 at 9:00 a.m. PT, all shareholders will be able to submit and upvote questions for Coinbase management by visiting here. This Q&A platform will remain open until 24 hours before the earnings call. Shareholders can email [email protected] for any support inquiries. The live webcast

      7/9/25 4:10:00 PM ET
      $COIN
      Finance: Consumer Services
      Finance
    • Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer

      Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services' (CMS) Molecular Diagnostic Services Program (MolDX) for serial use in patients with stage II, III and resectable stage IV colorectal cancer (CRC) in the adjuvant and recurrence monitoring settings over a five-year period. The final LCD can be found here, and the billing and coding article here, from CMS. This marks a significant milestone in the company's mission to transform cancer treatment through earlier detection and more personalize

      7/9/25 6:00:00 AM ET
      $EXAS
      Medical Specialities
      Health Care
    • KULR Technology Group Announces $20 Million Credit Facility with Coinbase

      HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), a Bitcoin First Company and global leader in sustainable energy management, announced today that it has secured a $20 million credit facility with Coinbase Credit, Inc., a subsidiary of Coinbase Global, Inc. (NASDAQ:COIN). The agreement establishes a multi-draw loan facility initially totaling up to $20 million, which will be available to KULR upon execution of the credit facility ("Effective Date"). The Company intends to use the net proceeds to fund its strategic Bitcoin accumulation goals. "This marks KULR's first bitcoin-backed credit facility, giving us access to non-dilutiv

      7/8/25 8:00:00 AM ET
      $COIN
      $KULR
      Finance: Consumer Services
      Finance
      Electrical Products
      Technology

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Leadership Updates

    Live Leadership Updates

    See more
    • Dataminr Appoints Tiffany Buchanan as Chief Financial Officer to Accelerate Strategic Growth and Public Market Readiness

      Former CrowdStrike finance leader brings deep expertise in scaling high-growth technology companies, and will partner with Dataminr's leadership team to drive global expansion and operational scale  NEW YORK, June 26, 2025 /PRNewswire/ -- Dataminr, the leading real-time AI platform, today announced the appointment of Tiffany Buchanan as Chief Financial Officer. Buchanan is a highly accomplished executive with a proven track record of accelerating growth, leading IPO readiness, and operating at scale in the public market. Drawing upon more than 20 years of experience leading g

      6/26/25 9:00:00 AM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology
    • Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

      CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced the appointment of Claire Mazumdar, Ph.D., to the Company's Board of Directors, effective June 9, 2025. "It is a privilege to welcome Claire to our Board, where she will draw from her strategic and operational experience in clinical-stage oncology to offer guidance as we prepare to initiate our Phase 3 ReDiscover-2 trial in breast cancer soon," said Sanjiv Patel, M.D., President and Chief Executive Officer of Relay Therapeutics.

      6/11/25 4:05:00 PM ET
      $BCAX
      $RLAY
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Biotechnology: Biological Products (No Diagnostic Substances)
    • CrowdStrike Appoints Brad Burns as Chief Communications Officer

      Former Salesforce and Snowflake CCO to drive comms strategy for CrowdStrike's next phase of growth and innovation CrowdStrike (NASDAQ:CRWD) today announced the appointment of Brad Burns as chief communications officer (CCO). Burns will lead the company's global communications strategy, supporting executive leadership as CrowdStrike accelerates its growth and scale as cybersecurity's platform innovator for the AI era. "CrowdStrike's mission to stop breaches has never been more important. As adversaries weaponize AI – lowering the bar to launch and scale attacks – communicating the power of the Falcon platform to defeat modern threats is critical to businesses around the world," said George

      5/13/25 8:01:00 AM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Financials

    Live finance-specific insights

    See more
    • Coinbase Announces Date of Second Quarter 2025 Financial Results

      Coinbase Global, Inc. (the "Company" or "Coinbase") announced today that it will publish its second quarter 2025 shareholder letter, including financial results, on its Investor Relations website at investor.coinbase.com on Thursday, July 31, 2025, after market close. The Company will hold a question and answer session to discuss its financial results at 2:30 p.m. PT that same day. Starting on July 24 at 9:00 a.m. PT, all shareholders will be able to submit and upvote questions for Coinbase management by visiting here. This Q&A platform will remain open until 24 hours before the earnings call. Shareholders can email [email protected] for any support inquiries. The live webcast

      7/9/25 4:10:00 PM ET
      $COIN
      Finance: Consumer Services
      Finance
    • CrowdStrike Reports First Quarter Fiscal Year 2026 Financial Results

      Ending ARR surpasses $4.4 billion, adding $194 million in net new ARR Delivers strong Falcon Flex deal momentum with accounts exceeding $3.2 billion in total deal value, growing more than 6x year-over-year Achieves record cash flow from operations of $384 million and robust free cash flow of $279 million Announces share repurchase authorization of up to $1 billion CrowdStrike Holdings, Inc. (NASDAQ:CRWD), today announced financial results for the first quarter fiscal year 2026, ended April 30, 2025. "We started the fiscal year with record Q1 large deal and MSSP momentum alongside sustained 97% gross retention and consistently strong net retention as the market consolidates on

      6/3/25 4:05:00 PM ET
      $CRWD
      $MSFT
      Computer Software: Prepackaged Software
      Technology
    • Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results

      - Initiated Phase 3 registrational ECLIPSE program in chronic hepatitis delta with first patient enrolled in Q1 2025; Program received U.S. FDA Breakthrough and Fast Track designations and EMA PRIME and Orphan Drug designations - Dose escalation continues for PRO-XTEN™ dual-masked T-cell engagers VIR-5818 (HER2) and VIR-5500 (PSMA) - On track to initiate a Phase 1 study of VIR-5525, the PRO-XTEN™ dual-masked EGFR-targeting T-cell engager, in the second quarter of 2025 - 24-week post-treatment data from Phase 2 MARCH study in chronic hepatitis B to be presented at EASL on May 9; Further development requires partner - Strong financial position with approximately $1.0 billion in cash and i

      5/7/25 4:05:00 PM ET
      $VIR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $COIN
    $CRWD
    $EXAS
    $RLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Coinbase Global Inc.

      SC 13G/A - Coinbase Global, Inc. (0001679788) (Subject)

      11/14/24 5:44:24 PM ET
      $COIN
      Finance: Consumer Services
      Finance
    • Amendment: SEC Form SC 13G/A filed by Coinbase Global Inc.

      SC 13G/A - Coinbase Global, Inc. (0001679788) (Subject)

      11/14/24 5:40:50 PM ET
      $COIN
      Finance: Consumer Services
      Finance
    • Amendment: SEC Form SC 13G/A filed by CrowdStrike Holdings Inc.

      SC 13G/A - CrowdStrike Holdings, Inc. (0001535527) (Subject)

      11/14/24 1:22:38 PM ET
      $CRWD
      Computer Software: Prepackaged Software
      Technology